◀ Back to WNT6
SOX9 — WNT6
Text-mined interactions from Literome
Dong et al., J Cell Physiol 2006
(Hypertrophy) :
Wnt8c and Wnt9a strongly
inhibited mRNA levels of
Sox9 and type II collagen ( col2a1 ) ... Wnt8c further enhanced canonical bone morphogenetic proteins ( BMP-2 ) -induced expression of Runx2 and col10a1 while
Wnt8c and Wnt9a
inhibited TGF-beta induced expression of
Sox9 and col2a1
Wang et al., Cancer Res 2007
(Neoplasm Recurrence, Local...) :
SOX9 message and protein levels in prostate cancer cells were increased by treatment with glycogen synthase kinase 3beta inhibitor ( SB415286 ), and SOX9 was reduced when beta-catenin was down-regulated by small interfering RNA ( siRNA ), indicating that
SOX9 expression in prostate cancer is
regulated by
Wnt/beta-catenin signaling
Topol et al., J Biol Chem 2009
:
Sox9 inhibits
Wnt signaling by promoting beta-catenin phosphorylation in the nucleus ... Chondrocyte fate determination and maintenance requires
Sox9 , an intrinsic transcription factor, but is
inhibited by
Wnt/beta-catenin signaling activated by extrinsic Wnt ligands
Kormish et al., Dev Dyn 2010
(Neoplasms) :
In some contexts,
Wnt signaling also
regulates SOX expression resulting in feedback regulatory loops that fine-tune cellular responses to beta-catenin/TCF activity
Geetha-Loganathan et al., BMC developmental biology 2010
:
To investigate the molecular nature of the inhibitory influence of the ectoderm, we ectopically expressed Wnt6, which is presently the only known Wnt expressed throughout the avian limb ectoderm, and found that
Wnt6 overexpression
leads to reduced expression of the early chondrogenic marker genes
Sox9 and Collagen II
Bernard et al., Endocrinology 2012
:
Wnt signaling in ovarian development
inhibits Sf1 activation of
Sox9 via the Tesco enhancer ... Ectopic activation of
Wnt/ß-catenin signaling in male gonads
led to a loss of Sf1 binding to the Tesco enhancer and absent
Sox9 expression that we also observed in wild-type ovaries ... Moreover, ectopic
Wnt/ß-catenin signaling induced the expression of the female somatic cell markers, Bmp2 and Rspo1, as a likely
consequence of
Sox9 loss
Wang et al., J Biol Chem 2013
(Breast Neoplasms...) :
Consistently,
SOX9 overexpression in BCa cell lines and transgenic SOX9 expression in breast epithelium
caused increased LRP6 and TCF4 expression and
Wnt/ß-catenin activation ... These results identify
SOX9 mediated
Wnt/ß-catenin activation as one of the molecular mechanisms underlying aberrant Wnt/ß-catenin activity in BCa, especially in the BL-BCa subgroup